Zai Lab Limited ADR [ZLAB] stock is trading at $36.42, up 2.91%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZLAB shares have gain 5.14% over the last week, with a monthly amount glided 35.24%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zai Lab Limited ADR [NASDAQ: ZLAB] stock has seen the most recent analyst activity on March 07, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $55. Previously, BofA Securities downgraded its rating to Neutral on March 03, 2025, and elevated its price target to $36.10. On December 14, 2023, Morgan Stanley initiated with a Overweight rating and assigned a price target of $47.50 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $70 on August 10, 2023. Macquarie initiated its recommendation with a Outperform and recommended $64 as its price target on January 21, 2022. In a note dated April 28, 2020, Goldman initiated an Buy rating.
Zai Lab Limited ADR [ZLAB] stock has fluctuated between $13.48 and $36.60 over the past year. Currently, Wall Street analysts expect the stock to reach $50 within the next 12 months. Zai Lab Limited ADR [NASDAQ: ZLAB] shares were valued at $36.42 at the most recent close of the market. An investor can expect a potential return of 37.29% based on the average ZLAB price forecast.
Analyzing the ZLAB fundamentals
Zai Lab Limited ADR [NASDAQ:ZLAB] reported sales of 398.99M for the trailing twelve months, which represents a growth of 65.68%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at -0.64%, and Net Profit Margin reading is -0.64%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.35 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.12 points at the first support level, and at 33.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.86, and for the 2nd resistance point, it is at 39.29.
Ratios To Look Out For
For context, Zai Lab Limited ADR’s Current Ratio is 3.51. Further, the Quick Ratio stands at 3.38, while the Cash Ratio is 1.5. Considering the valuation of this stock, the price to sales ratio is 9.96, the price to book ratio is 4.67.
Transactions by insiders
Recent insider trading involved Du Ying, Officer, that happened on Mar 05 ’25 when 46389.0 shares were purchased. Director, GAYNOR RICHARD completed a deal on Mar 05 ’25 to buy 2500.0 shares. Meanwhile, Chief Legal Officer Edmondson Frazor Titus III sold 14544.0 shares on Feb 28 ’25.
